Uploaded October 2016 | Updated September 2026, 2 days ago
One on One with Murali Prahalad, Ph.D.
President & CEO, Epic Sciences
Advisory Board, Department of Biomedical Informatics, Harvard Medical School
TOPIC: Demystifying Liquid Biopsies – How Cutting-edge Diagnostics are Generating New Insights for Therapy Selection and Resistance Monitoring in Cancer
INTERVIEWER: Florence Comite, M.D.
BIO: Murali Prahalad, Ph. D. is the president and CEO of Epic Sciences. Dr. Prahalad has more than 14 years of experience in technology and life science companies. Prior to joining Epic, he was formerly vice president of Corporate Strategy at Life Technologies, where he helped shape the organic and inorganic investment priorities across Life Technologies' research tools, clinical diagnostic and applied market portfolios. Dr. Prahalad was with Life Technologies since 2005, where he held multiple positions of increasing responsibility. His experience at Life Technologies ranged from mergers and acquisitions to in licensing and general management, where he led large businesses that spanned genomics to cell biology. As a general manager, he had to grow revenue and profit by building stronger teams, driving innovation and managing operations for both consumable and instrument portfolios. Prior to Life Technologies, he was vice president of Business Development at Sequenom, Inc. He is also proficient and literate in several languages including Japanese, French and Kannada. Dr. Prahalad received a Ph.D. in biochemistry and molecular pharmacology and an M.S. in medical sciences from Harvard University, and he received his B.S. with honors in cellular and molecular biology and economics from the University of Michigan.Meet the new medical paradigm
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
One on One with Murali Prahalad, Ph.D.
President & CEO, Epic Sciences
Advisory Board, Department of Biomedical Informatics, Harvard Medical School
TOPIC: Demystifying Liquid Biopsies – How Cutting-edge Diagnostics are Generating New Insights for Therapy Selection and Resistance Monitoring in Cancer
INTERVIEWER: Florence Comite, M.D.
BIO: Murali Prahalad, Ph. D. is the president and CEO of Epic Sciences. Dr. Prahalad has more than 14 years of experience in technology and life science companies. Prior to joining Epic, he was formerly vice president of Corporate Strategy at Life Technologies, where he helped shape the organic and inorganic investment priorities across Life Technologies' research tools, clinical diagnostic and applied market portfolios. Dr. Prahalad was with Life Technologies since 2005, where he held multiple positions of increasing responsibility. His experience at Life Technologies ranged from mergers and acquisitions to in licensing and general management, where he led large businesses that spanned genomics to cell biology. As a general manager, he had to grow revenue and profit by building stronger teams, driving innovation and managing operations for both consumable and instrument portfolios. Prior to Life Technologies, he was vice president of Business Development at Sequenom, Inc. He is also proficient and literate in several languages including Japanese, French and Kannada. Dr. Prahalad received a Ph.D. in biochemistry and molecular pharmacology and an M.S. in medical sciences from Harvard University, and he received his B.S. with honors in cellular and molecular biology and economics from the University of Michigan.Meet the new medical paradigm
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
